CDC Now Recommends RSV Vaccine for Some Adults 50+
By I. Edwards HealthDay Reporter
MONDAY, July 7, 2025 — Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update from the U.S. Centers for Disease Control and Prevention (CDC).
This marks a change from the CDC’s previous recommendation, which only offered the shot to people 60 and older who were at high risk, The Associated Press reported.
Respiratory syncytial virus, or RSV, is usually mild but can cause severe illness in infants, older adults and people with certain health problems. It affects the nose, throat and lungs.
Earlier this year, a group of vaccine experts on the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to expand RSV vaccination to high-risk adults starting at age 50.
However, that recommendation was not executed after Health Secretary Robert F. Kennedy Jr. fired all 17 members of the panel in June.
He replaced them with seven new members, some of whom have questioned vaccine effectiveness.
The reconstituted panel has not discussed RSV vaccination again and has already caused concern among doctors by questioning proven science around flu vaccines and childhood immunizations, The AP said.
Despite this, a page on the CDC’s website updated last week says Kennedy approved the original panel’s RSV recommendation on June 25.
The site now states that vaccinating high-risk adults 50 and older is an “official recommendation of the CDC,” The AP added.
The change has not yet appeared on the agency’s main adult immunization schedule.
The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV.
It also recommends the shot during pregnancy to protect newborns.
Sources
- The Associated Press, July 2, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
COVID Vaccines Saved More Than 2.5 Million Lives, Mostly Seniors
MONDAY, July 28, 2025 — More than 2.5 million deaths were prevented worldwide by the cutting-edge vaccines developed for COVID-19, mainly among seniors, a new analysis...
U.S. to Remove Mercury Preservative From Flu Jabs
FRIDAY, July 25, 2025 — It's official: The controversial preservative thimerosal will be stripped from all flu vaccines distributed in the United States. According to the...
COVID Boosters Protect People With Cancer
WEDNESDAY, July 23, 2025 — Cancer patients can be very vulnerable to a severe COVID infection, but COVID-19 vaccine boosters can be lifesavers for them, a new study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.